skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello!

What is your current take on the company? They have reported what would appear promising two quarters as far as revenue while successively reducing their costs yet the stock has done nothing since it first bottomed in September. Overall there is not much movement despite of volatility. Any thoughts would be greatly appreciated.
Read Answer Asked by Irek on November 24, 2020
Q: Hello Peter,
Namaste seems to follow the Amazon model and if they get the medical sales license, they could do quite well given their international exposure. Signing a deal with Tilray was a good endorsement;however, it is unclear at this point, what really transpired that would cause Tilray to cancel the agreement. I have not seen any official release from either company other than the Quebec newspaper article. The stock is down quite a bit. What should one do in this case? If the agreement is truly cancelled, should one sell or hang on as the overall model looks good. My concern is could the perception of the company be ruined and hence investor perception? Thanks
Read Answer Asked by umedali on September 18, 2018
Q: I have read all of the answers regarding Namaste and it does not seem that you find it very attractive;however, given the latest announcements on the medical and the recreational side, do you now feel it has good potential from here. The company seems to be landing good agreements for distribution and their medical side seems interesting. My only concern is what stops the big players from replicating their model? Thanks
Read Answer Asked by umedali on September 05, 2018
Q: I read your December response on this stock. It seems that their vaporizer product line required appropriate distribution channels to generate realistic returns. Apparently, the company has entered into a joint venture with one of the weed companies,which should bolster sales volumes.
Although still a high risk investment, the stock might probably be more palatable at this point. Would you agree?
Z
Read Answer Asked by Sigrid on January 04, 2018
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!